VolitionRx Files 8-K: Bylaws, Shareholder Votes, Financials
Ticker: VNRX · Form: 8-K · Filed: Jun 20, 2025 · CIK: 93314
Sentiment: neutral
Topics: corporate-governance, financials, bylaws
Related Tickers: VNRX
TL;DR
VNRX filed an 8-K: bylaws updated, shareholder votes, and financials released. Watch for updates.
AI Summary
VolitionRx Limited filed an 8-K on June 20, 2025, reporting events as of June 18, 2025. The filing indicates amendments to articles of incorporation or bylaws, submission of matters to a vote of security holders, and the filing of financial statements and exhibits. The company, incorporated in Delaware, is in the business of in vitro & in vivo diagnostic substances.
Why It Matters
This 8-K filing signals important corporate governance actions and the release of financial information, which can impact investor understanding of VolitionRx's operational and strategic direction.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant negative news or immediate financial distress.
Key Players & Entities
- VolitionRx Limited (company) — Registrant
- June 18, 2025 (date) — Earliest event reported
- June 20, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- 2835 (industry_code) — Standard Industrial Classification
FAQ
What specific amendments were made to VolitionRx's articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote, but the nature of these matters is not detailed in the provided text.
When were the financial statements and exhibits filed?
The filing indicates that financial statements and exhibits were filed as part of this 8-K report, which was filed on June 20, 2025.
What is VolitionRx Limited's Standard Industrial Classification code?
VolitionRx Limited's Standard Industrial Classification code is 2835, which pertains to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
What is the business address of VolitionRx Limited?
The business address of VolitionRx Limited is 1489 West Warm Springs Road, Suite 110, Henderson, Nevada 89014.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding VOLITIONRX LTD (VNRX).